TwinStrand Biosciences

OverviewSuggest Edit

TwinStrand Biosciences is a company that develops Duplex Sequencing technology aimed at DNA sequencing. It tracks and compares strands of individual DNA molecules to eliminate errors and increase accuracy, detecting the rarest variants of artifactual mutations. The company aims to enable more informed critical decisions in clinical medicine, public health, and other fields of science.

TypePrivate
Founded2015
HQSeattle, WA, US
Websitetwinstrandbio.com
Overall CultureA+

Latest Updates

Employees (est.) (Nov 2021)88(+5%)
Job Openings14
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at TwinStrand Biosciences

Jesse Salk

Jesse Salk

Chief Executive Officer, Chief Scientific Officer, Director
Steve Dow

Steve Dow

Director
Chad Waite

Chad Waite

Chairman of the Board
Elena Cant

Elena Cant

Chief Operating Officer
D. Gary Gilliland

D. Gary Gilliland

Director
S. Somasegar

S. Somasegar

Director
Show more

TwinStrand Biosciences Office Locations

TwinStrand Biosciences has an office in Seattle
Seattle, WA, US (HQ)
3131 Elliott Ave #750
Show all (1)

TwinStrand Biosciences Financials and Metrics

Summary Metrics

Founding Date

2015

TwinStrand Biosciences total Funding

$23.2 m

TwinStrand Biosciences latest funding size

$16 m

Time since last funding

2 years ago

TwinStrand Biosciences investors

TwinStrand Biosciences's latest funding round in January 2020 was reported to be $16 m. In total, TwinStrand Biosciences has raised $23.2 m
Show all financial metrics

TwinStrand Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

C

76/100

SecurityScorecard logo

TwinStrand Biosciences Online and Social Media Presence

Embed Graph

TwinStrand Biosciences Company Culture

  • Overall Culture

    A+

    97/100

  • CEO Rating

    A+

    100/100

  • Compensation

    A+

    100/100

Learn more on Comparably

TwinStrand Biosciences News and Updates

TwinStrand Biosciences Licenses Duplex Sequencing Technology to Foundation Medicine

SEATTLE, Nov. 18, 2020 /PRNewswire/ -- TwinStrand Biosciences today announced it has entered into a worldwide non-exclusive agreement to sublicense two foundational patent families to Foundation Medicine and its affiliates relating to TwinStrand Duplex Sequencing™ error-correction...

TwinStrand Biosciences Frequently Asked Questions

  • When was TwinStrand Biosciences founded?

    TwinStrand Biosciences was founded in 2015.

  • Who are TwinStrand Biosciences key executives?

    TwinStrand Biosciences's key executives are Jesse Salk, Steve Dow and Chad Waite.

  • How many employees does TwinStrand Biosciences have?

    TwinStrand Biosciences has 88 employees.

  • Who are TwinStrand Biosciences competitors?

    Competitors of TwinStrand Biosciences include Human Longevity, GenePlanet and Centogene.

  • Where is TwinStrand Biosciences headquarters?

    TwinStrand Biosciences headquarters is located at 3131 Elliott Ave #750, Seattle.

  • Where are TwinStrand Biosciences offices?

    TwinStrand Biosciences has an office in Seattle.

  • How many offices does TwinStrand Biosciences have?

    TwinStrand Biosciences has 1 office.